Does NIVOLUMAB Cause Systemic inflammatory response syndrome? 65 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Systemic inflammatory response syndrome have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.1% of all adverse event reports for NIVOLUMAB.
65
Reports of Systemic inflammatory response syndrome with NIVOLUMAB
0.1%
of all NIVOLUMAB reports
10
Deaths
58
Hospitalizations
How Dangerous Is Systemic inflammatory response syndrome From NIVOLUMAB?
Of the 65 reports, 10 (15.4%) resulted in death, 58 (89.2%) required hospitalization, and 18 (27.7%) were considered life-threatening.
Is Systemic inflammatory response syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 65 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Systemic inflammatory response syndrome?
DOXORUBICIN (161)
METHOTREXATE (158)
CYCLOPHOSPHAMIDE (153)
CYTARABINE (153)
METHYLPREDNISOLONE (117)
ADALIMUMAB (107)
RITUXIMAB (106)
PREDNISOLONE (99)
VINCRISTINE (97)
MYCOPHENOLATE MOFETIL (95)
Which NIVOLUMAB Alternatives Have Lower Systemic inflammatory response syndrome Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE